What is the address of Dr. Line Vermeulen - Huisarts?

The registered office of Dr. Line Vermeulen - Huisarts is located at Gaversesteenweg 348, 9820 Merelbeke-Melle.

Is Dr. Line Vermeulen - Huisarts still active?

Yes. According to the CBE (18 September 2026) Dr. Line Vermeulen - Huisarts is active, legal situation “Normale toestand”, started on 14 November 2018.

Is Dr. Line Vermeulen - Huisarts registered on Peppol?

Yes, Dr. Line Vermeulen - Huisarts is registered on the Peppol network with ID 0208:0713537740.

What is the enterprise number of Dr. Line Vermeulen - Huisarts?

The enterprise number of Dr. Line Vermeulen - Huisarts is BE0713537740.

When was Dr. Line Vermeulen - Huisarts founded?

Dr. Line Vermeulen - Huisarts was founded on 14 November 2018.

Is Dr. Line Vermeulen - Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 November 2018; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Dr. Line Vermeulen - Huisarts make in 2025?

Dr. Line Vermeulen - Huisarts posted a profit after taxes of € 55,589 in financial year 2025.

What is the revenue of Dr. Line Vermeulen - Huisarts?

As a small company, Dr. Line Vermeulen - Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 91,771.

Dr. Line Vermeulen - Huisarts (Private Limited)

Dossier Dr. Line Vermeulen - Huisarts, printed on 18 September 2026 from databakkes.be/en/0713537740/dr-line-vermeulen-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Line Vermeulen - Huisarts from Merelbeke-Melle, company number BE0713537740, closed financial year 2025 with a result of € 55,589 after tax. For that financial year Dr. Line Vermeulen - Huisarts recorded a gross margin of € 91,771 and equity of € 18,600. Compared with financial year 2024, the result moved from € 62,770 to € 55,589. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 26, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 55,589

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 83,595

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,589 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 25,205

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 9,283

▼ 45% vs 2024

€ 7,928 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 158

▼ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 53,115 Gross margin 2022: € 53,115 First fiscal year in the series	€ 117,605 Gross margin 2023: € 117,605 ▲ 121% vs 2022 (€ 53,115) Favourable step	€ 101,662 Gross margin 2024: € 101,662 ▼ 14% vs 2023 (€ 117,605) Unfavourable step	€ 91,771 Gross margin 2025: € 91,771 ▼ 10% vs 2024 (€ 101,662) Unfavourable step	▼ 10%
Profit after taxes	€ 39,867 Profit after taxes 2022: € 39,867 First fiscal year in the series	€ 73,268 Profit after taxes 2023: € 73,268 ▲ 84% vs 2022 (€ 39,867) Favourable step	€ 62,770 Profit after taxes 2024: € 62,770 ▼ 14% vs 2023 (€ 73,268) Unfavourable step	€ 55,589 Profit after taxes 2025: € 55,589 ▼ 11% vs 2024 (€ 62,770) Unfavourable step	▼ 11%
Equity	€ 18,600 Equity 2022: € 18,600 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2024: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 172,890 Total debts 2022: € 172,890 First fiscal year in the series	€ 179,488 Total debts 2023: € 179,488 ▲ 4% vs 2022 (€ 172,890) Unfavourable step	€ 120,692 Total debts 2024: € 120,692 ▼ 33% vs 2023 (€ 179,488) Favourable step	€ 112,608 Total debts 2025: € 112,608 ▼ 7% vs 2024 (€ 120,692) Favourable step	▼ 7%
Cash	€ 158,524 Cash 2022: € 158,524 First fiscal year in the series	€ 126,574 Cash 2023: € 126,574 ▼ 20% vs 2022 (€ 158,524) Unfavourable step	€ 83,858 Cash 2024: € 83,858 ▼ 34% vs 2023 (€ 126,574) Unfavourable step	€ 83,595 Cash 2025: € 83,595 Unchanged (€ 83,858) Unfavourable step
Dividend	€ 158,716 Dividend 2022: € 158,716 First fiscal year in the series	€ 73,268 Dividend 2023: € 73,268 ▼ 54% vs 2022 (€ 158,716) Unchanged	€ 62,770 Dividend 2024: € 62,770 ▼ 14% vs 2023 (€ 73,268) Unchanged	€ 55,589 Dividend 2025: € 55,589 ▼ 11% vs 2024 (€ 62,770) Unchanged	▼ 11%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 24,164 Bank debt 2023: € 24,164 Unchanged (€ 0) Unfavourable step	€ 16,881 Bank debt 2024: € 16,881 ▼ 30% vs 2023 (€ 24,164) Favourable step	€ 9,283 Bank debt 2025: € 9,283 ▼ 45% vs 2024 (€ 16,881) Favourable step	▼ 45%
Balance sheet total	€ 191,490 Balance sheet total 2022: € 191,490 First fiscal year in the series	€ 198,088 Balance sheet total 2023: € 198,088 ▲ 3% vs 2022 (€ 191,490) Unchanged	€ 139,292 Balance sheet total 2024: € 139,292 ▼ 30% vs 2023 (€ 198,088) Unchanged	€ 131,208 Balance sheet total 2025: € 131,208 ▼ 6% vs 2024 (€ 139,292) Unchanged	▼ 6%

Key figures of Dr. Line Vermeulen - Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Line Vermeulen - Huisarts?

What happened at Dr. Line Vermeulen - Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 26, 2026 New annual accounts for financial year 2025: profit of € 55,589 (▼ 11% vs 2024). Source: NBB ↗
Nov 14, 2018 New establishment in Gent. KBO
Nov 14, 2018 Start of the company according to the CBE. KBO

In short

From € 39,867 profit in 2022 to € 55,589 profit in 2025.

Paid € 82,310 in corporate taxes since 2022.

Best year ever: 2023, with € 73,268 profit.

Paid out € 350,344 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Line Vermeulen - Huisarts? We notify you, reason included.

Follow Dr. Line Vermeulen - Huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Gaversesteenweg 348

9820 Merelbeke-Melle

2.281.965.085

Hagedisstraat 3

9000 Gent

Active since 14 November 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BRE4 Consulting

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0713.537.740
VAT number: BE 0713.537.740
Registered office: Gaversesteenweg 348, 9820 Merelbeke-Melle
Names & denominations: Dr. Line Vermeulen - Huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 November 2018
Peppol: Active · Active since 26 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Line Vermeulen - Huisarts